Roche and BioLamina start collaboration to develop novel cell culture systems
March 6, 2013
Roche (SIX: RO, ROG; OTCQX: RHHBY) and BioLamina, Stockholm, Sweden today announced the signing of a research and development agreement to jointly develop new cell culture systems for various applications, including stem cell research. The collaboration will focus on assessing laminin-based in-vitro cell culture matrices offering highly physiological microenvironments for living cells. Under the terms [...]
FDA approves new Roche test to evaluate response to hepatitis C therapy
March 6, 2013
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the US Food and Drug Administration (FDA) for a next-generation viral load test to be used in the management of patients with chronic hepatitis C virus (HCV) infection. The COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0 provides a novel dual-probe approach, for [...]
EnviroLogix Launches Rapid Molecular Test Kit for Salmonella
March 6, 2013
Portland, ME,– EnviroLogix Inc. has introduced the DNAble Salmonella Rapid Screening Kit, a pioneering testing solution for live poultry production. At a luncheon during the International Production and Processing Expo in Atlanta, EnviroLogix was joined by poultry industry leaders to unveil the new technology and present performance data. Kathy S. Hensley, General Laboratory Manager at [...]
March 6, 2013
SEATTLE and BALTIMORE, Md. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that results presented at the 2013 United States & Canadian Academy of Pathology annual meeting validate the analytical reproducibility of the company’s Prosigna™ Breast Cancer Prognostic Gene Signature Assay. Prosigna, [...]
March 6, 2013
Aliso Viejo, CA – Ambry Genetics, a global leader in clinical diagnostics and genomic services, announced today that they have officially reached a new milestone in Next-Gen sequencing. “We have reached an incredible milestone in next-generation sequencing (NGS)," said Ardy Arianpour, Vice President of Business Development at Ambry Genetics." Ever since NGS was launched, we [...]
Conductivity Sensor from Sensorex Ideal for Sanitary Applications
March 5, 2013
Garden Grove, California – Sensorex’s CS615 Conductivity sensor monitors process fluids for changes within this critical parameter. With two sanitary tri clamp flange sizes available, the sterilizable sensors are ideal for food, pharmaceutical and other contamination-sensitive services where sanitary connections are desired. The 316 stainless steel construction withstands both cleaning in place and steam sterilization [...]
March 5, 2013
The NS300 utilizes the latest version of NanoSight's particle characterization technology, Nanoparticle Tracking Analysis (NTA). This elegant new instrument offers all the unique benefits scientists have come to expect from NanoSight in an easy to use and compact format. The NS300 can visualize and measure particles in suspension in the size range 10-2000 nm (depending [...]
African Aviation Security Customer Purchases Three More Quantum Sniffers From Implant Sciences
March 5, 2013
WILMINGTON, MA -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold three more Quantum Sniffer™ QS-H150 handheld explosives trace detectors in a follow-on order to a customer in Africa. The units are to be deployed for aviation security. "Historically, [...]
Japan’s Narita International Airport Selects Morpho’s CTX 9800 EDS for Hold Baggage Screening
March 5, 2013
Newark, Calif. - Morpho (Safran), through its subsidiary Morpho Detection, Inc., today announced the Narita International Airport Corporation in Japan has purchased 13 high-speed CTX 9800 DSi™ explosives detection systems (EDS) for hold baggage screening. The latest evolution of Morpho's industry-leading CTX™ family of EDS, CTX 9800 is U.S. Transportation Security Administration (TSA)-certified as high-speed, [...]
March 5, 2013
Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, announced today it has received approval from the U.S. Food and Drug Administration for the addition of Kadcyla in the labeling of two Dako companion diagnostic assays. Kadcyla (ado-trastuzumab emtansine) is Genentech's new medicine for patients with HER2-positive metastatic breast cancer who have received [...]
